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Methods and Results: We included prospectively the 42 consecutive
patients (younger than 75 yo) implanted in the University Hospital of Tou-
louse with ACC/AHA/ESC indications for CRT. Characteristics of the popu-
lation were: male sex 88%, ischemic cardiomyopathy 45%, mean  LVEF 22%,
mean QRS duration 160ms, CRT-D 98%. The echocardiographic (Pulsed
Doppler and Tissue Doppler Imaging) parameters of cardiac dysynchrony
were obtained at baseline and six month (or more) after CRT implant. We
defined the responder group as an improvement in 1 NYHA class and no hos-
pitalisation for heart failure (HF) during the follow up (mean duration 15
month). 62% (n=26) were clinical responders. The echocardiographic assess-
ment was done at 11 (6 to 20) month. There was no statistically significant
difference between the “residual” mechanical dysynchrony of the responders
versus the non-responders. Considering only the responders, there is no reduc-
tion of LIVD at six month after CRT. A baseline aortic pre-ejection delay >
140 ms, a non ischemic cardiomyopathy  and the left ventricular activation
time measured before implantation  with a method described recently by
Sweeney et al are the only factors of response to CRT.
Conclusions: The clinical response to CRT is not well correlate with the
“residual” mechanical LIVD such as we measured by echocardiography (DTI
and PD).
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Background: Cardiac Resynchronization Therapy (CRT) improves mor-
bidity and mortality in systolic heart failure. Elderly patients are under repre-
sented in large clinical trials although incidence of heart failure is high in this
population.
Method: we considered 146 consecutive patients  75 years old with stan-
dard indication for CRT implanted between 2005 and 2007. Mean age was 79
yo, 72 % males, EF= 27%, ischemic heart disease (IHD) 46%, Atrial Fibrilla-
tion 54%, CRT-D: 16%. Minimal follow-up was 12 months.  Total mortality,
clinical improvement (gain > 1 NYHA class without hospitalization for con-
gestive heart failure) and combined criteria (mortality and clinical improve-
ment) were retrospectively assessed.
Results: Mean follow-up is 25 +/-12 months. Data are complete for 137
patients (94.2%).
Survival rate is 65%, clinical improvement is achieved in 51% and combined
criteria in 45%.
Independent factors of non response (p<0.10) are summarized in the table.
Causes of deaths are: terminal heart failure: 35 pts, sudden cardiac death: 1 pt,
non cardiac death: 13 pts and unknown: 2 pts.
Conclusion: CRT is effective in elderly patients. Factors of non response
are similar to those observed in younger population. CRT-P appears to be the
most suitable device for this population.
(Voir tableau ci-dessous) 
195
Mechanical dyssyncrony and response to cardiac resynchronization
therapy in patients with narrow QRS complex.
Caroline Dussault (1), Erwan Donal (2), Patricia Réant (3), Stéphane
Lafitte (3), Raymond Roudaut (3), Gilbert Habib (3), Pascal Gueret (1),
Pascal Lim (1)
(1) CHU Henri Mondor, Fédération de cardiologie, Créteil, France - (2)
CHU Rennes, Rennes, France - (3) CHU Bordeaux, Bordeaux, France
Objective: To assess whether LV mechanical dyssynchrony may be used
to predict response to CRT in patients with narrow QRS complex (<120ms).
Methods: CRT was performed in 183 symptomatic heart failure patients
(64±12 years, EF=25±8%) with narrow (n=41) and wide QRS complex
(n=142). Mechanical dyssynchrony before CRT implantation was quantified
by the 12 segment standard deviation of peak longitudinal strain by speckle
tracking (12SD) and the strain delay index (SDI) defined as the sum of differ-
ence between end systolic and peak strain across the 16 segments. 
Results: Before CRT, wide and narrow QRS patients had similar 12SD
(100±32ms vs. 105±35ms) and SDI (36±14% vs. 38±15%). However, in wide
QRS patients, QRS duration decreased after CRT (143±35ms vs. 120±34ms,
p<0.0001) and ESV reduction (mean= -21%, ESVR>15% in 66%, 92/139)
correlated with SDI (r=0.41, p<0.0001) and 12SD (r=0. 21, p=0.01) before
CRT. In contrast, in narrow QRS population, QRS duration increased after
CRT (96±16ms vs. 108±28ms, p=0.006) and ESV reduction (Mean=-11%,
ESVR>15% in 39% (25/41) failed to correlate with mechanical dyssynchrony
before CRT. Importantly, increase in QRS duration after CRT in narrow QRS
population was associated with adverse remodeling (r=0.43, p=0.01) and
tended to correlate with an increase in SDI after CRT (r=0.32, p=0.08). 
Conclusion: Response to CRT does not correlate to the importance of
mechanical dyssynchrony in narrow QRS population. The benefice of CRT
despite a significant LV dyssynchrony appears counterbalanced by a signifi-
cant QRS enlargement after CRT implantation in narrow QRS population. 
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Background: Cardiac resynchronisation therapy (CRT) has been shown to
improve clinical status in heart failure patients. Some patients treated by CRT
fail to respond to the treatment. Predisposing factors for non-response should
be investigated to optimize patient selection. 
Objective: The purpose of the study was to evaluate before device implan-
tation and 3, 6 and 12 month after, echocardiographic and biological parame-
ters with respect to  CRT response. 
Methods: Thirty two patients with heart failure (72% of men ; age 66 ± 10
years; 59 % non-ischaemic cardiomyopathy; NYHA III-IV; left ventricular
ejection fraction (LVEF) 22.7 ± 6.7 %; QRS width 146 ± 26 ms) were
implanted with CRT device and followed during twelve month. Responders
Multivariate analysis
OR (IC 95%)
Combined criteria Total
Mortality 
Clinical improvement
NYHA IV
IHD
CRT-D 
Atrial fibrillation
No ACEI /ARB
Renal failure ( creatinine > 10µm/l)
Doses of diuretics 
4,1 (1.5-12.4)
2,2 (1-4.8)
NS
2,7 (1.3-5.8)
2,7 (0.9-8.8)
1,1 (1-1.2)
NS
3.1 (1.2-8.5)
3.4 (1.5-7.9)
3.2 (1.2-8.8)
2.2 (1-5.1)
NS
NS
1.03 (1-1.1)
2.5 (1-6.6)
NS
NS
NS
NS
1.2 (1.1-1.3)
NS
